scispace - formally typeset
Search or ask a question
Author

David Cameron

Bio: David Cameron is an academic researcher from University of Oslo. The author has contributed to research in topics: Large Hadron Collider & Breast cancer. The author has an hindex of 154, co-authored 1586 publications receiving 126067 citations. Previous affiliations of David Cameron include Universidade Nova de Lisboa & Cameron International.


Papers
More filters
Journal ArticleDOI
Georges Aad1, Brad Abbott2, J. Abdallah, S. Abdel Khalek  +3083 moreInstitutions (192)
TL;DR: In this article, the internal substructure of jets generated by QCD radiation is tested on an inclusive sample of jets recorded with the ATLAS detector in 2010, which corresponds to 35 pb(-1) of pp collisions delivered by the LHC at root s = 7 TeV.
Abstract: Recent studies have highlighted the potential of jet substructure techniques to identify the hadronic decays of boosted heavy particles. These studies all rely upon the assumption that the internal substructure of jets generated by QCD radiation is well understood. In this article, this assumption is tested on an inclusive sample of jets recorded with the ATLAS detector in 2010, which corresponds to 35 pb(-1) of pp collisions delivered by the LHC at root s = 7 TeV. In a subsample of events with single pp collisions, measurements corrected for detector efficiency and resolution are presented with full systematic uncertainties. Jet invariant mass, k(t) splitting scales and N-subjettiness variables are presented for anti-k(t) R = 1.0 jets and Cambridge-Aachen R = 1.2 jets. Jet invariant-mass spectra for Cambridge-Aachen R = 1.2 jets after a splitting and filtering procedure are also presented. Leading-order parton-shower Monte Carlo predictions for these variables are found to be broadly in agreement with data. The dependence of mean jet mass on additional pp interactions is also explored.

153 citations

Journal ArticleDOI
TL;DR: Recommendations for the definitions of TTE end points commonly used in RCTs for breast cancer are provided for non-metastatic and metastatic settings and should facilitate comparisons of trial results and improve the quality of trial design and reporting.

152 citations

Journal ArticleDOI
Helena M. Earl1, Helena M. Earl2, Helena M. Earl3, Louise Hiller4, Anne-Laure Vallier1, Shrushma Loi4, Karen McAdam5, Karen McAdam1, Luke Hughes-Davies1, Adrian Harnett6, Mei-Lin Ah-See7, Richard Simcock8, Daniel Rea9, Sanjay Raj10, Pamela Woodings11, Mark Harries12, Donna L. Howe4, Kerry Raynes4, Helen B Higgins4, Maggie Wilcox, Chris Plummer13, Chris Plummer14, Janine Mansi12, Ioannis Gounaris15, Betania Mahler Araujo1, Elena Provenzano1, Elena Provenzano2, Anita Chhabra1, Jean Abraham1, Jean Abraham2, Jean Abraham3, Carlos Caldas, Peter Hall16, Christopher McCabe, Claire Hulme17, Claire Hulme18, David Miles7, Andrew M Wardley19, David Cameron16, Janet A. Dunn4, Roshan Agarwal, Hafiz Algurafi, Rozenn Allerton, Caroline Archer, Anne C Armstrong, Catherine Bale, Lisa H Barraclough, Urmila Barthakur, Carolyn Bedi, Kim Benstead, D. Bloomfield, Rebecca Bowen, Chris Bradley, Jane Brown, Mohammad Butt, Mark Churn, Susan Cleator, Joanne Cliff, Perric Crellin, Margaret Daly, Shiroma De Silva-Minor, A.S. Dhadda, O.S. Din, Sue Down, H. M. Earl, David J. Eaton, Andrew Eichholz, Daniel Epurescu, Chee Goh, Andrew D. Goodman, Robert Grieve, Maher Hadaki, Catherine Harper-Wynne, Larry Hayward, A. Humphreys, Helen Innes, Mariam Jafri, Apurna Jegannathen, Muireann Kelleher, Hartmut Kristeleit, Daniela Lee, Susan Lupton, Carol MacGregor, Zafar Malik, Jennifer Marshall, Trevor McGolick, Rakesh Mehra, Natasha Mithal, Charlotte Moss, Aian Moss, Mukesh Mukesh, Anthony Neal, Daniel Nelmes, Helen Neville-Webbe, Jacqueline Newby, S O'Reilly, Peter Ostler, Mojca Persic, Laura Pettit, Fharat A. Raja, Catherine Reed, Anne Rigg, Helen Roe, Nihal Shah, Peter Simmonds, Eliot Sims, Sarah Smith, Nicola Storey, Wendy Taylor, Narottam Thanvi, Karen Tipples, Jayant S. Vaidya, Mohini Varughese, Anup Vinayan, Nawaz Walji, Simon Waters, Kathryn Wright, Sundus Yahya 
TL;DR: 6-month trastuzumab treatment is shown to be non-inferior to 12-month treatment in patients with HER2-positive early breast cancer, with less cardiotoxicity and fewer severe adverse events, which support consideration of reduced duration trastzumab for women at similar risk of recurrence as to those included in the trial.

151 citations


Cited by
More filters
Journal ArticleDOI
TL;DR: The GLOBOCAN 2020 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer (IARC) as mentioned in this paper show that female breast cancer has surpassed lung cancer as the most commonly diagnosed cancer, with an estimated 2.3 million new cases (11.7%), followed by lung cancer, colorectal (11 4.4%), liver (8.3%), stomach (7.7%) and female breast (6.9%), and cervical cancer (5.6%) cancers.
Abstract: This article provides an update on the global cancer burden using the GLOBOCAN 2020 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer. Worldwide, an estimated 19.3 million new cancer cases (18.1 million excluding nonmelanoma skin cancer) and almost 10.0 million cancer deaths (9.9 million excluding nonmelanoma skin cancer) occurred in 2020. Female breast cancer has surpassed lung cancer as the most commonly diagnosed cancer, with an estimated 2.3 million new cases (11.7%), followed by lung (11.4%), colorectal (10.0 %), prostate (7.3%), and stomach (5.6%) cancers. Lung cancer remained the leading cause of cancer death, with an estimated 1.8 million deaths (18%), followed by colorectal (9.4%), liver (8.3%), stomach (7.7%), and female breast (6.9%) cancers. Overall incidence was from 2-fold to 3-fold higher in transitioned versus transitioning countries for both sexes, whereas mortality varied <2-fold for men and little for women. Death rates for female breast and cervical cancers, however, were considerably higher in transitioning versus transitioned countries (15.0 vs 12.8 per 100,000 and 12.4 vs 5.2 per 100,000, respectively). The global cancer burden is expected to be 28.4 million cases in 2040, a 47% rise from 2020, with a larger increase in transitioning (64% to 95%) versus transitioned (32% to 56%) countries due to demographic changes, although this may be further exacerbated by increasing risk factors associated with globalization and a growing economy. Efforts to build a sustainable infrastructure for the dissemination of cancer prevention measures and provision of cancer care in transitioning countries is critical for global cancer control.

35,190 citations

Journal ArticleDOI

[...]

08 Dec 2001-BMJ
TL;DR: There is, I think, something ethereal about i —the square root of minus one, which seems an odd beast at that time—an intruder hovering on the edge of reality.
Abstract: There is, I think, something ethereal about i —the square root of minus one. I remember first hearing about it at school. It seemed an odd beast at that time—an intruder hovering on the edge of reality. Usually familiarity dulls this sense of the bizarre, but in the case of i it was the reverse: over the years the sense of its surreal nature intensified. It seemed that it was impossible to write mathematics that described the real world in …

33,785 citations

Journal ArticleDOI
01 Nov 2009-Thyroid
TL;DR: Evidence-based recommendations are developed to inform clinical decision-making in the management of thyroid nodules and differentiated thyroid cancer and represent, in the authors' opinion, contemporary optimal care for patients with these disorders.
Abstract: Background: Thyroid nodules are a common clinical problem, and differentiated thyroid cancer is becoming increasingly prevalent. Since the American Thyroid Association's (ATA's) guidelines for the management of these disorders were revised in 2009, significant scientific advances have occurred in the field. The aim of these guidelines is to inform clinicians, patients, researchers, and health policy makers on published evidence relating to the diagnosis and management of thyroid nodules and differentiated thyroid cancer. Methods: The specific clinical questions addressed in these guidelines were based on prior versions of the guidelines, stakeholder input, and input of task force members. Task force panel members were educated on knowledge synthesis methods, including electronic database searching, review and selection of relevant citations, and critical appraisal of selected studies. Published English language articles on adults were eligible for inclusion. The American College of Physicians Guideline Gr...

10,501 citations

Journal ArticleDOI
01 Apr 1988-Nature
TL;DR: In this paper, a sedimentological core and petrographic characterisation of samples from eleven boreholes from the Lower Carboniferous of Bowland Basin (Northwest England) is presented.
Abstract: Deposits of clastic carbonate-dominated (calciclastic) sedimentary slope systems in the rock record have been identified mostly as linearly-consistent carbonate apron deposits, even though most ancient clastic carbonate slope deposits fit the submarine fan systems better. Calciclastic submarine fans are consequently rarely described and are poorly understood. Subsequently, very little is known especially in mud-dominated calciclastic submarine fan systems. Presented in this study are a sedimentological core and petrographic characterisation of samples from eleven boreholes from the Lower Carboniferous of Bowland Basin (Northwest England) that reveals a >250 m thick calciturbidite complex deposited in a calciclastic submarine fan setting. Seven facies are recognised from core and thin section characterisation and are grouped into three carbonate turbidite sequences. They include: 1) Calciturbidites, comprising mostly of highto low-density, wavy-laminated bioclast-rich facies; 2) low-density densite mudstones which are characterised by planar laminated and unlaminated muddominated facies; and 3) Calcidebrites which are muddy or hyper-concentrated debrisflow deposits occurring as poorly-sorted, chaotic, mud-supported floatstones. These

9,929 citations